跳至主要内容
临床试验/ACTRN12623001030662
ACTRN12623001030662招募中Unknown

ong-term abdominal drains in refractory ascites due to end stage liver disease, a pilot study

Southern Adelaide Local Health Network0 个研究点目标入组 20 人开始时间: 2023年9月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Age >18 years with capacity to consent for treatment
  • Patient with mild cognitive impairment, at treating doctor and/or PI’s discretion
  • Refractory ascites
  • Ascites that is unresponsive to fluid and sodium restriction, and high-dose diuretic treatment (spironolactone 400 mg/day and/or furosemide 160 mg/day) with or without intolerance to diuretics
  • Ascites that recurs rapidly after LVP (requiring one or more LVP/month).
  • Considered ineligible to undergo LT and or trans jugular intrahepatic portosystemic shunts (TIPSS)

排除标准

  • Patients with loculated ascites
  • Patients with large exophytic liver tumours
  • Patients with chronic abdominal pain
  • Patients with extensive abdominal wall scars
  • Patients unlikely to tolerate with abdominal drains at home as judged by the treating medical team
  • Patients with active spontaneous bacterial peritonitis

研究者

发起方
Southern Adelaide Local Health Network

相似试验